What Are Assault Weapons -- And Who Makes Them?

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
What Are Assault Weapons -- And Who Makes Them?



Early in the 2016 presidential campaign, Sen. Bernie Sanders and former Secretary of State Hillary Clinton feuded openly and often on the issue of gun control. Now, the tragic shootings in Orlando, Fla. have put gun control back at center stage.

This week, the U.S. Senate debated four separate bills to further regulate the use and sale of guns, touching on ideas ranging from beefing up the background check system to banning the sale of firearms to anyone on a terror watch list. None of the bills passed in the Senate, but gun control remains a major topic among the media and politicians.

In the immediate aftermath of Orlando, retired generals David Petraeus and Stanley McChrystal and former astronaut Mark Kelly joined a coalition of military veterans calling for new laws "to keep dangerous people from having easy access to guns." McChrystal in particular has averred, "I personally don't think there's any need for [assault weapons] on the streets and particularly around the schools in America."
Define the term

Firearms characterized as "assault weapons" played a role in the mass shootings at Cleveland Elementary School in California in 1989, at Columbine in 1999, at Sandy Hook Elementary School and in Aurora, Colo. in 2012, the Umpqua Community College shootings in Oregon in 2015, and now, in the attack in Orlando as well.

But what exactly are "assault weapons"?

According to popular pro-gun website assaultweapon.info, the phrase "assault weapons" is often confused with the more precise term "assault rifle". Specifically, an assault rifle is a machine gun such as an M4A1 carbine (pictured above), which can fire both semi-automatically (pull the trigger once, and one bullet comes out) or automatically (hold the trigger, and the weapon keeps firing till empty).

With a few exceptions, the sale or purchase of assault rifles is illegal in the United States -- and has been tightly regulated since 1986.

In contrast, weapons that resemble assault rifles cosmetically but are incapable of full-automatic fire have been popularly referred to as "assault weapons" -- a term that gained legal significance with the federal Assault Weapons Ban in 1994. In the U.S., this class of firearm includes such semi-automatic rifles as the AR-15 and certain AK-47 variants, as well as large semi-automatic pistols such as the TEC-9 and semi-automatic carbines firing pistol-caliber ammunition.

The Wall Street Journal sums up the difference thusly: So-called assault weapons "look like machine guns, but they do not function like machine guns." Rather, they "function like every other normal firearm -- they fire only one bullet each time the trigger is pressed."
A distinction with differences

The 1994 Assault Weapons Ban expired in 2004 and was not renewed. Still, one question remains: If true assault rifles (i.e., machine guns) are already mostly illegal, why would the government also ban semi-automatic weapons that only resemble assault rifles while permitting the sale of .22-caliber target rifles, .308-caliber hunting rifles, and other firearms that operate exactly the same way?

Some critics see a difference in muzzle velocity. Citing data from gun manufacturer Sturm, Ruger (NYSE:RGR), PublicHealthWatch has argued that the muzzle velocity of an AR-15 rifle firing 5.56 NATO or .223 caliber ammunition can be several times higher than the velocity of a .22 target rifle, for example, with correspondingly greater destructive power.

Magazine capacity is another factor. Generally speaking, you can pack more 5.56 mm or .223-caliber ammunition into an "assault weapon" magazine than a similar-size magazine on a more powerful .308 hunting rifle. That said, there are .308 magazines for sale that can carry 50 rounds, and large-capacity .22 magazines can hold in excess of 100 rounds -- just as there are .223-caliber drum magazines holding 100 rounds. And keep in mind that the typical .308 bullet weighs two to three times as much as the 5.56 NATO.

Honestly, I think the Violence Policy Center, a gun control organization, hits closest to the mark when it argues in favor of banning "assault weapons", because those are the easiest targets. Says VPC: Assault weapons' "menacing looks, coupled with the public's confusion over fully automatic machine guns versus semi-automatic assault weapons ... increase the chance of public support for restrictions on these weapons."

So "menacing looks" may be the crux of the matter. When you get down to it, the movement to ban assault weapons begins to resemble a marketing campaign -- and, in fact, a marketing campaign that worked once before, in 1994.

Will it work again? And what would that mean for investors in the gun industry?

Last week's failed efforts to enact new firearms regulations in the immediate aftermath of Orlando suggests gun reform efforts will not succeed this year. But with a presidential election in the offing, and the potential for a change of control in the House and Senate, there's no telling what might happen next year.

Just the chance of new regulation could send gun owners stampeding to the gun store to stock up on guns 'n' ammo "before they ban them." And this, in turn, could send investors stampeding to buy shares of gun stocks. But which gun stocks in particular? Which companies make "assault weapons" anyway, and which companies' stocks are likely to benefit?
Round up the usual suspects

It's almost easier to tell you who doesn't make them. Sturm, Ruger, Smith & Wesson (NASDAQ:SWHC), and even privately owned Bushmaster all make various versions of the AR-15. And while Bushmaster is not publicly traded, Sturm, Ruger and Smith & Wesson most definitely are -- they're also the two most likely beneficiaries of surging demand for firearms.

Both Sturm, Ruger and Smith & Wesson make AR-15 variants that fit the popular conception of what an assault weapon looks like -- even if their guns are not assault rifles. And while the average price-to-earnings ratio of stocks on the S&P 500 is more than 24 times, both Sturm, Ruger and Smith & Wesson sell for P/E multiples in the mid-teens -- making them attractive investment options.

As the drumbeat for gun regulation gets louder, the case for buying Sturm, Ruger and Smith & Wesson stock will only get stronge
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Faces Lawsuit: Investor Unrest Unfolds

Updated Category News Views 5

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 74

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 25

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
SWFI's I20 Summit Spotlights 3,000 Promising Start-Ups

Updated Category News Views 42

Spotlight on Emerging Titans: The Future 100 Watchlist The Sovereign Wealth Fund Institute is rattling the investment cages with their latest stunt, the 'Future 100 Watchlist.' Hot off the press, this list is parading nearly 3,000 start-ups that are biting at the heels of future success. It's high stakes and higher hopes between December 11-16 at Miami's I20 Summit, where...

Continue Reading
Artprice Bridges Art and AI Across the Hispanic World

Updated Category News Views 11

A Monumental Launch with Deep Roots I've been around long enough to see all sorts of moves in the art world and the tech world. But what Artprice by Artmarket is pulling off here—it’s a doozy. Thierry Ehrmann’s “Diálogo entre un pensador y la IA” just went live in Spanish, and that’s not some paperback thrill ride. We’re talking about an 1,800-page piece of...

Continue Reading
Tulsa Hosts Gradient's Global Tech and Investment Event

Updated Category News Views 21

Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...

Continue Reading
SOPHiA GENETICS' Q3 2026: Revenue Growth & Challenges

Updated Category News Views 7

Unpacking SOPHiA GENETICS' Third Quarter Figures Let's cut through the jargon and get straight to the brass tacks. SOPHiA GENETICS (NASDAQ:SOPH) just posted their third quarter numbers for 2026, and it’s a mixed bag, my friends. Sure, they boasted a 25% bump in revenue, hitting $24.3 million, but the devil's in the details—net losses nudged up to $20.3 million, not...

Continue Reading
Marathon Petroleum's Massive Q3 2026 Profit Surge

Updated Category News Views 13

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Continue Reading
Newcomers, Veterans Elevate NYSE's Tokenization Efforts

Updated Category News Views 89

Breaking New Ground at the NYSE When the bell rings at the NYSE these days, it's not just marking the start of another trading session. It's the sound of change clanging its way onto Wall Street. On November 3, 2026, the NYSE threw its hat deeper into the tokenization ring, a game-changer perhaps. They've roped in some big guns—Securitize, tZERO, Broadridge Financial...

Continue Reading
Illumina's Role in Singapore's Precision Medicine Leap

Updated Category News Views 160

Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...

Continue Reading

Top 5 Most Recently Viewed Articles

Rising Demand and Technological Advancements in Krill Meal Market

Updated Category News Views 226

Understanding the Expanding Krill Meal Market The krill meal market is undergoing remarkable growth, fueled by a shift in consumer preferences favoring clean-label food products and natural flavor enhancers. According to recent estimates, the market is poised to expand significantly, reaching an impressive valuation by the end of an upcoming decade. This growth can be...

Continue Reading
Tango Therapeutics Begins Dosing in Pivotal Cancer Trial

Updated Category News Views 224

Tango Therapeutics Begins Dosing in Pivotal Cancer Trial BOSTON — Tango Therapeutics, Inc. (NASDAQ: TNGX), a dynamic biotechnology company dedicated to revolutionizing cancer care, has achieved a pivotal milestone by dosing the first patient in its TNG456 Phase 1/2 trial aimed at patients with MTAP-deleted solid tumors, particularly glioblastoma (GBM). Known for its...

Continue Reading
Investors Invited to Explore Class Action against Rentokil Initial

Updated Category News Views 188

Investors Encouraged to Join Class Action Against Rentokil Initial Bronstein, Gewirtz & Grossman, LLC, a well-respected law firm known for its expertise in securities cases, is reaching out to investors of Rentokil Initial Plc. This communication centers around a class action lawsuit that has been filed on behalf of those affected by some significant events concerning the...

Continue Reading
Murphy USA's Dividend Boost: A Commitment to Shareholders

Updated Category News Views 78

Murphy USA's Dividend Boost Reflects Confidence in Growth Murphy USA Inc. (NYSE: MUSA), a well-known player in the gasoline and convenience store sector, has recently announced an increase in its quarterly cash dividend. The company's Board has declared a new dividend of $0.48 per share, which represents a notable 6.7% rise from the previous dividend. This increase...

Continue Reading
Cloudinary Enhances Digital Asset Management with New Features

Updated Category News Views 181

Cloudinary's Innovative Update to Digital Asset Management Today, Cloudinary, the leading image and video platform, revealed significant advancements in its API-first digital asset management (DAM) solution. These enhancements are designed to address the evolving needs of brands in managing their visual assets efficiently and effectively. With a focus on streamlining...

Continue Reading